Maxigen Biotech Inc. (1783)의 가격은 얼마입니까?

Maxigen Biotech Inc. (1783)의 가격은 $1.28입니다.

Maxigen Biotech Inc. (1783)의 시가 총액은 무엇입니까?

Maxigen Biotech Inc. (1783)의 시가 총액은 $115.23M입니다.

Maxigen Biotech Inc. (1783) 액면분할

Maxigen Biotech Inc. (MBI) is a company dedicated to the research, development, production, and global commercialization of advanced biomedical and skincare solutions. Its extensive biomedical portfolio includes various orthopedic products such as Formagraft, a bone graft substitute, and Formasetin, a bone void filler. For intra-articular applications in orthopedics, MBI markets injections under the names ArtiAid, ArtiAid Plus, and ArtiBest. The company's offerings also span both orthopedic and dental fields, featuring Foramic, a bone substitute granule; MaxiBone, a calcium phosphate ceramic; and GingivAid, a collagen dental graft. Specifically for dental use, MBI provides FormaAid, a collagen membrane, and the E-TECH DENTISTAR II sterilizer and disinfectant. Furthermore, HealiAid, a collagen wound dressing product, serves dental and general wound care purposes. MBI also manufactures ophthalmic viscoelastic devices, known as ViscAid, PreviscAid, and BiVisc, and produces Formaderm, a dermal filler injection utilized in plastic surgery. Beyond its medical devices, Maxigen Biotech Inc. offers a comprehensive line of skincare products. This array includes masks for the face, neck, body, and limbs, alongside make-up removers, cleansers, exfoliants, toners, essences, men's grooming items, sunscreens, and specialized body, hand, and foot care formulations. Maxigen Biotech Inc. was established in 1998 and operates from its main office in Taoyuan City, Taiwan.

연도	주식 분할	배수	누적 배수
제공된 날짜에 대한 데이터가 충분하지 않습니다.

연도

주식 분할

배수

누적 배수

제공된 날짜에 대한 데이터가 충분하지 않습니다.

회사	주식 분할 횟수	누적 배수	국가
Intuitive Surgical, Inc. ISRG.US	3	x4	US
EssilorLuxottica S.A. EL.PA	3	x20	FR
HOYA Corporation 7741.T	0	-	JP
Becton, Dickinson and Company BDX.US	6	x20	US
Alcon Inc. ALC.SW	0	-	CH

회사

주식 분할 횟수

누적 배수

국가